These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32358591)

  • 1. 10 years of biosimilars: lessons and trends.
    Royzman I; Shah K
    Nat Rev Drug Discov; 2020 Jun; 19(6):375. PubMed ID: 32358591
    [No Abstract]   [Full Text] [Related]  

  • 2. The US Biosimilar Market: Stunted Growth and Possible Reforms.
    Sarpatwari A; Barenie R; Curfman G; Darrow JJ; Kesselheim AS
    Clin Pharmacol Ther; 2019 Jan; 105(1):92-100. PubMed ID: 30415479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosimilars battle rages on, Amgen fights both sides.
    Senior M
    Nat Biotechnol; 2013 Apr; 31(4):269-70. PubMed ID: 23563402
    [No Abstract]   [Full Text] [Related]  

  • 4. Patent litigation could make 2017 no 'dancing' matter.
    Reinke T
    Manag Care; 2016 Dec; 25(12):23-28. PubMed ID: 28121555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparability conundrum: biosimilars in the United States, Europe and Canada.
    Courage N; Parsons A
    Food Drug Law J; 2011; 66(2):203-24, i-ii. PubMed ID: 24505840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Science Behind Biosimilars: Entering a New Era of Biologic Therapy.
    Bridges SL; White DW; Worthing AB; Gravallese EM; O'Dell JR; Nola K; Kay J; Cohen SB;
    Arthritis Rheumatol; 2018 Mar; 70(3):334-344. PubMed ID: 29411547
    [No Abstract]   [Full Text] [Related]  

  • 7. Biosimilars: Key regulatory considerations and similarity assessment tools.
    Kirchhoff CF; Wang XM; Conlon HD; Anderson S; Ryan AM; Bose A
    Biotechnol Bioeng; 2017 Dec; 114(12):2696-2705. PubMed ID: 28842986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights of biosimilars through SWOT analysis.
    Patel MM; Shah PJ; Patel BM
    Expert Opin Biol Ther; 2014 Feb; 14(2):139-44. PubMed ID: 24151903
    [No Abstract]   [Full Text] [Related]  

  • 9. The Biosimilar Pipeline Seams Seem To Be Bursting.
    Reinke T
    Manag Care; 2017 Mar; 26(3):24-25. PubMed ID: 28510516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA sets hierarchy for biosimilars evidence.
    Ratner M
    Nat Biotechnol; 2014 Jul; 32(7):609. PubMed ID: 25004221
    [No Abstract]   [Full Text] [Related]  

  • 11. Biosimilars in the United States: Emerging Issues in Litigation.
    Wong AY; Rumore MM; Chan AW
    BioDrugs; 2017 Jun; 31(3):189-205. PubMed ID: 28424972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in the early development of biosimilar products.
    Li EC; Abbas R; Jacobs IA; Yin D
    Drug Discov Today; 2015 May; 20 Suppl 2():1-9. PubMed ID: 25572407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label promotion.
    Somberg J
    Am J Ther; 2006; 13(5):387. PubMed ID: 16988530
    [No Abstract]   [Full Text] [Related]  

  • 14. First US biosimilar edges towards market.
    Senior M
    Nat Biotechnol; 2015 Mar; 33(3):222-3. PubMed ID: 25748898
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosimilar safety factors in clinical practice.
    Reinisch W; Smolen J
    Semin Arthritis Rheum; 2015 Jun; 44(6 Suppl):S9-15. PubMed ID: 26058551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Development. Are trade secrets delaying biosimilars?
    Price WN; Rai AK
    Science; 2015 Apr; 348(6231):188-9. PubMed ID: 25859034
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA Expectations for Demonstrating Interchangeability.
    Chance K
    Ther Innov Regul Sci; 2018 May; 52(3):369-373. PubMed ID: 29714562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indiana jumps the biosimilars gun.
    Fox JL
    Nat Biotechnol; 2014 May; 32(5):406. PubMed ID: 24811502
    [No Abstract]   [Full Text] [Related]  

  • 19. First biosimilar drug approved for sale in the United States.
    Hede K
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142444
    [No Abstract]   [Full Text] [Related]  

  • 20. The complexities of biosimilars and the regulatory approval process.
    Lucio S
    Am J Manag Care; 2018 Jun; 24(11 Suppl):S231-S236. PubMed ID: 29957908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.